Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ST3-H5149 | Human | Human STAT3 Protein, His Tag (MALS & SPR verified) |  |
|
|
Human STAT3, His Tag (Cat. No. ST3-H5149) immobilized on CM5 Chip can bind STAT3 degrader with an affinity constant of 44.6 nM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Caffeic Acid | CABE | Approved | The University Of Texas MD Anderson Cancer Center, Moleculin Llc | Hemorrhage; Leukopenia; Thrombocytopenia | Details | |||||
| Golotimod | SCV-07 | Approved | Verta | Russian Federation | Hepatitis C; Mucositis | null | 2009-01-01 | Head and Neck Neoplasms; Hepatitis C; Mucositis; Stomatitis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| GLG-302 | GLG-302; GLG-805; S31-201; NSC-74859 | Phase 1 Clinical | H Lee Moffitt Cancer Center & Research Institute | Breast Neoplasms | Details |
| M-1001 | M-1001; MEDICA-M1001 | Phase 2 Clinical | Syndromex | Dyslipidemias | Details |
| Amcasertib/Napabucasin | Phase 1 Clinical | Boston Biomedical Inc | Neoplasms | Details | |
| HL-237 | HL-237 | Phase 2 Clinical | Hanlim Pharmaceutical Co Ltd | Arthritis, Rheumatoid | Details |
| Danvatirsen | AZD-9150; STAT-3Rx; ISIS-345794; ISIS-481464; ISIS-STAT3Rx; IONIS-STAT3Rx; ISIS-STAT3-2.5Rx; IONIS-STAT3-2.5Rx | Phase 2 Clinical | Ionis Pharmaceuticals Inc | Ovarian Neoplasms; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Ascites; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| CO-sTiRNA | CO-sTiRNA | Phase 1 Clinical | City Of Hope National Medical Center | Solid tumours; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
| KT-333 | KT-333; I-003 | Phase 1 Clinical | Kymera Therapeutics Inc | Solid tumours; Lymphoma, T-Cell, Peripheral; Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic | Details |
| WP-1066 | WP-1066 | Phase 1 Clinical | The University Of Texas MD Anderson Cancer Center | Medulloblastoma; Neoplasms; Glioblastoma; Brain Neoplasms; Brain metastases; Glioma; Melanoma | Details |
| Napabucasin | DP1; DP2A; BB-608; GB-201; BBI-608; BBI-608-DP1; BBI-608-DP2A; Z1HHM49K7O (UNII code) | Phase 3 Clinical | 1globe Biomedical Co Ltd, Pharmaceutics International Inc, Boston Biomedical Inc | Solid tumours; Hematologic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Neoplasms; Glioblastoma; Mesothelioma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms | Details |
| C-188-9 | C188-9; C-188-9; TTI-101 | Phase 2 Clinical | Baylor College Of Medicine | Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular | Details |
| NT-219 | NT-219; NT219 | Phase 2 Clinical | TyrNovo Ltd | Head and Neck Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Neoplasm Metastasis | Details |
| Dimethylaminomicheliolide Fumarate | ACT-001 | Phase 2 Clinical | Accendatech Co Ltd | Ganglioglioma; Glioblastoma; Optic Neuritis; Central Nervous System Neoplasms; Neuromyelitis Optica; Breast Neoplasms; Glioma; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung | Details |
| PCUR-101 | PCUR-101 | Phase 1 Clinical | Pellficure Pharmaceuticals Inc | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
